SCHEMBL27166314

SCHEMBL27166314

CCCCOc1ccc(CC(CO)NCc2ccc(OC)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 1/20 0.47
ADRB3 P13945 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 1/20 0.45
TSHR P16473 1/20 0.45
HTT P42858 1/20 0.45
ALDH1A1 P00352 1/20 0.43
ALOX12 P18054 1/20 0.43
ADRB2 P07550 4/20 0.43
ACACB O00763 1/20 0.43
FAAH O00519 1/20 0.43
KDM4E B2RXH2 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
PDE4A P27815 1/20 0.42
HIF1A Q16665 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27166267 1.00 ADRB1 (0.47) ADRB1ADRB3SMN1; SMN2LMNATSHR
SCHEMBL27166264 0.89 ADRB1 (0.48) ADRB1ADRB3LMNAALDH1A1ALOX12
SCHEMBL27166224 0.89 ACACB (0.46) ADRB1ADRB3SMN1; SMN2LMNATSHR
SCHEMBL27166305 0.89 ACACB (0.46) ADRB1ADRB3SMN1; SMN2LMNATSHR
SCHEMBL27166309 0.88 ACACB (0.45) ADRB1ADRB3SMN1; SMN2LMNATSHR
SCHEMBL27166280 0.88 ACACB (0.45) ADRB1ADRB3SMN1; SMN2LMNATSHR
SCHEMBL27166365 0.88 ACACB (0.45) ADRB1ADRB3SMN1; SMN2LMNATSHR
SCHEMBL27166253 0.88 ACACB (0.45) ADRB1ADRB3SMN1; SMN2LMNATSHR
SCHEMBL27166242 0.86 ADRB3 (0.44) ADRB1ADRB3TSHRALDH1A1ALOX12
SCHEMBL27166297 0.86 ADRB3 (0.44) ADRB1ADRB3TSHRALDH1A1ALOX12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4584251-A1 NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING Bayer Aktiengesellschaft (DE) 2025-07-16 EP disclosed
WO-2024052549-A1 NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING BAYER AKTIENGESELLSCHAFT (DE) 2024-03-14 WO disclosed
EP-4335840-A1 NEW CONTRAST AGENTS FOR USE IN DIAGNOSTIC IMAGING Bayer Aktiengesellschaft (DE) 2024-03-13 EP disclosed